Formosa Laboratories Inc
Formosa Laboratories, Inc., together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. The company offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulator… Read more
Market Cap & Net Worth: Formosa Laboratories Inc (4746)
Formosa Laboratories Inc (TW:4746) has a market capitalization of $200.27 Million (NT$6.63 Billion) as of March 18, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #16181 globally and #621 in its home market, demonstrating a 2.42% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Formosa Laboratories Inc's stock price NT$55.10 by its total outstanding shares 120256000 (120.26 Million).
Formosa Laboratories Inc Market Cap History: 2015 to 2026
Formosa Laboratories Inc's market capitalization history from 2015 to 2026. Data shows growth from $215.87 Million to $200.27 Million (0.49% CAGR).
Formosa Laboratories Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Formosa Laboratories Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Formosa Laboratories Inc's market cap is 0.05 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.59x
Formosa Laboratories Inc's market cap is 1.59 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $215.87 Million | $2.60 Billion | $282.39 Million | 0.08x | 0.76x |
| 2016 | $317.30 Million | $3.19 Billion | $483.44 Million | 0.10x | 0.66x |
| 2017 | $228.33 Million | $2.54 Billion | $238.65 Million | 0.09x | 0.96x |
| 2018 | $131.65 Million | $2.69 Billion | $176.82 Million | 0.05x | 0.74x |
| 2019 | $145.82 Million | $2.76 Billion | -$41.06 Million | 0.05x | N/A |
| 2020 | $163.59 Million | $3.08 Billion | $400.03 Million | 0.05x | 0.41x |
| 2021 | $210.81 Million | $3.14 Billion | $1.25 Billion | 0.07x | 0.17x |
| 2022 | $267.15 Million | $3.77 Billion | $216.81 Million | 0.07x | 1.23x |
| 2023 | $370.73 Million | $4.36 Billion | $126.24 Million | 0.09x | 2.94x |
| 2024 | $250.06 Million | $4.73 Billion | $157.27 Million | 0.05x | 1.59x |
Competitor Companies of 4746 by Market Capitalization
Companies near Formosa Laboratories Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Formosa Laboratories Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Formosa Laboratories Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Formosa Laboratories Inc's market cap moved from $215.87 Million to $ 200.27 Million, with a yearly change of 0.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$200.27 Million | -7.08% |
| 2025 | NT$215.53 Million | -13.81% |
| 2024 | NT$250.06 Million | -32.55% |
| 2023 | NT$370.73 Million | +38.78% |
| 2022 | NT$267.15 Million | +26.72% |
| 2021 | NT$210.81 Million | +28.86% |
| 2020 | NT$163.59 Million | +12.19% |
| 2019 | NT$145.82 Million | +10.77% |
| 2018 | NT$131.65 Million | -42.34% |
| 2017 | NT$228.33 Million | -28.04% |
| 2016 | NT$317.30 Million | +46.98% |
| 2015 | NT$215.87 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Formosa Laboratories Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $200.27 Million USD |
| MoneyControl | $200.27 Million USD |
| MarketWatch | $200.27 Million USD |
| marketcap.company | $200.27 Million USD |
| Reuters | $200.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.